ALZN — ALZAMEND NEURO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Oct 2026 | -0.23 | — | -0.23 | -0.23 | 1 | — |
| Jan 2027 | -0.22 | — | -0.22 | -0.22 | 1 | — |
| Apr 2027 | -0.22 | — | -0.22 | -0.22 | 1 | — |
| Jul 2027 | -0.22 | — | -0.22 | -0.22 | 1 | — |
| Oct 2027 | -0.22 | — | -0.22 | -0.22 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Apr 2027 | -1.05 | — | -1.05 | -1.05 | 1 | — |
| Apr 2028 | -0.87 | — | -0.87 | -0.87 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 15 SEC-registered investment managers reported holding ALZN (ALZAMEND NEURO INC) in their latest 13F filings, with a combined reported value of $2.36M across 1.36M shares. That is -13.0% by share count (-181.23K shares) versus the previous quarter, while reported value moved +25.4%. Ownership is concentrated: the five largest holders account for 95.3% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 4 opened new positions, 3 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ALZAMEND NEURO INC (ALZN) include Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, Citadel Advisors, ranked by reported 13F value among the 49 institutional holders on this page.
ALZN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 15 | 1.36M | $2.36M | -13.0% |
| Q2 2026 | 13 | 2.75M | $3.30M | +114.2% |
| Q1 2026 | 13 | 682.22K | $723.15K | +2.7% |
| Q4 2025 | 12 | 129.33K | $235.48K | +53.0% |
| Q3 2025 | 10 | 56.38K | $134.18K | +91.5% |
| Q2 2025 | 7 | 2.18K | $6.36K | -88.4% |
| Q1 2025 | 11 | 63.21K | $59.95K | +10.6% |
| Q4 2024 | 17 | 113.33K | $131.71K | -15.8% |
Over the 8 quarters shown, institutional share counts increased 1103% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+114.2%).
Top Institutional Holders (Q3 2026) — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.12M | $1.94M | 1.83% | Reduce | |
| 79.22K | $137.05K | 0.00% | New | |
| 36.20K | $62.63K | 0.00% | Add | |
| 34.39K | $59.50K | 0.00% | New | |
| 29.27K | $50.00K | 0.00% | New | |
| 26.26K | $45.44K | 0.00% | Hold | |
| 21.02K | $36.37K | 0.00% | Hold | |
| 10.90K | $18.86K | 0.00% | New | |
| 3.03K | $5.25K | 0.00% | Add | |
| 2.23K | $3.85K | 0.00% | Reduce | |
| 437 | $756 | 0.00% | Hold | |
| 22 | $38 | 0.00% | Hold | |
| 22 | $38 | 0.00% | Hold | |
| 4 | $7 | 0.00% | Add | |
| 1 | $2 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.33M | $1.59M | 1.35% | Add | |
| 1.33M | $1.59M | 0.52% | New | |
| 26.37K | $31.64K | 0.00% | New | |
| 26.37K | $31.64K | 0.00% | Reduce | |
| 21.02K | $25.22K | 0.00% | Hold | |
| 7.56K | $9.07K | 0.00% | Add | |
| 3.52K | $4.22K | 0.00% | Reduce | |
| 2.35K | $2.82K | 0.00% | Reduce | |
| 437 | $524 | 0.00% | Hold | |
| 22 | $26 | 0.00% | New | |
| 22 | $26 | 0.00% | Hold | |
| 3 | $4 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | Hold |
Q1 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 566.73K | $600.74K | 0.56% | New | |
| 45.68K | $48.42K | 0.00% | Add | |
| 21.02K | $22.28K | 0.00% | New | |
| 18.00K | $19.08K | 0.00% | Hold | |
| 10.00K | $10.60K | 0.00% | Hold | |
| 6.18K | $6.55K | 0.00% | Add | |
| 5.23K | $5.54K | 0.00% | New | |
| 4.50K | $4.77K | 0.00% | Reduce | |
| 4.40K | $4.66K | 0.00% | New | |
| 437 | $463 | 0.00% | Hold | |
| 22 | $23 | 0.00% | Hold | |
| 4 | $4 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q4 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.51K | $50.06K | 0.00% | Add | |
| 24.57K | $44.71K | 0.00% | Add | |
| 21.62K | $39.35K | 0.00% | Hold | |
| 18.00K | $32.76K | 0.00% | New | |
| 12.58K | $23.00K | 0.00% | New | |
| 12.47K | $22.70K | 0.00% | New | |
| 10.00K | $18.20K | 0.00% | Hold | |
| 2.08K | $3.79K | 0.00% | Add | |
| 437 | $795 | 0.00% | Hold | |
| 43 | $78 | 0.00% | Add | |
| 22 | $40 | 0.00% | Hold | |
| 1 | $2 | 0.00% | Hold |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 21.62K | $51.46K | 0.00% | New | |
| 20.58K | $48.97K | 0.00% | New | |
| 10.00K | $23.80K | 0.00% | New | |
| 2.08K | $4.94K | 0.00% | Add | |
| 1.61K | $3.82K | 0.00% | Add | |
| 437 | $1.04K | 0.00% | Reduce | |
| 37 | $88 | 0.00% | Add | |
| 22 | $52 | 0.00% | Hold | |
| 1 | $2 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Q2 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 902 | $2.62K | 0.00% | New | |
| 797 | $2.32K | 0.00% | New | |
| 441 | $1.28K | 0.00% | Reduce | |
| 22 | $64 | 0.00% | Add | |
| 19 | $55 | 0.00% | Reduce | |
| 2 | $6 | 0.00% | Reduce | |
| 1 | $3 | 0.00% | Reduce |
New Positions (Q3 2026)
- Citadel Advisors 79.22K sh · $137.05K
- JANE STREET GROUP, LLC 34.39K sh · $59.50K
- HRT FINANCIAL LP 29.27K sh · $50.00K
- STATE STREET CORP 10.90K sh · $18.86K
Fully Exited (vs previous quarter)
- KMT WEALTH MANAGEMENT, LLC sold 1.33M sh · $1.59M
- GEODE CAPITAL MANAGEMENT, LLC sold 26.37K sh · $31.64K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 1.12M | 1.33M | 566.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 79.22K | — | — | — | — | — | — | 30.64K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 36.20K | 7.56K | 4.40K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 34.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 29.27K | — | — | — | — | — | — | — | — | — | — | 16.81K | — | — | — | — | — | — | — |
| Geode Capital Management | 26.26K | 26.37K | 45.68K | 27.51K | 20.58K | — | 39.15K | 33.54K | — | 52.40K | 52.40K | 52.40K | 636.01K | — | — | 563.66K | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 21.02K | 21.02K | 21.02K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 10.90K | — | — | — | — | — | — | — | — | — | — | — | 31.90K | — | — | — | — | — | — |
| UBS Group AG | 3.03K | 2.35K | 4.50K | 24.57K | 2.08K | 902 | — | 820 | — | 5.13K | — | 1.91K | 7.93K | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 2.23K | 3.52K | 6.18K | 2.08K | 1.61K | 797 | — | 388 | 4.17K | 5.18K | 4.75K | 3.32K | 48.60K | — | — | — | — | — | — |
| BlackRock Inc | 437 | 437 | 437 | 437 | 437 | 441 | 3.97K | 3.97K | 3.97K | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 22 | 22 | 22 | 22 | 22 | 22 | 18 | 18 | — | — | — | — | — | — | — | — | — | — | — |
| IFG Advisory, LLC | 22 | 22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 4 | 3 | 4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HARBOR INVESTMENT ADVISORY, LLC | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 20 | 20 | 200 | 200 | 200 | 3.00K | — | — | — | — | — | — |
| KMT WEALTH MANAGEMENT, LLC | — | 1.33M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TRUIST FINANCIAL CORP | — | — | — | — | — | — | 15.50K | 15.50K | 15.50K | 154.99K | 154.33K | 154.33K | 2.31M | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 21.62K | 21.62K | — | — | — | — | 78.55K | 78.55K | 78.55K | 2.04M | — | — | — | — | — | — |
| GROUP ONE TRADING LLC | — | — | — | — | — | — | — | — | — | — | — | 85.90K | 86.00K | — | — | — | — | — | — |
| RFG Advisory, LLC | — | — | — | — | — | — | — | — | — | 16.67K | 16.67K | 16.67K | 250.00K | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ALZN?
As of 2026-Q3, 15 institutional funds reported holding ALZN (ALZAMEND NEURO INC) in SEC 13F filings, with a combined reported value of $2.36M.
How many shares of ALZN do institutions own?
13F filers reported 1.36M shares of ALZN, worth $2.36M in aggregate at the end of 2026-Q3.
Is institutional ownership of ALZN rising or falling?
Share counts moved -13.0% versus the prior quarter — distribution.
Who are the top institutional holders of ALZN?
The largest 13F holders are Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, Citadel Advisors, GROUP ONE TRADING LLC, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ALZAMEND NEURO INC?
The major shareholders of ALZAMEND NEURO INC (ALZN) by reported 13F value are Kingsbury Capital Investment Advisors LLC, KMT WEALTH MANAGEMENT, LLC, Citadel Advisors, GROUP ONE TRADING LLC, VANGUARD CAPITAL MANAGEMENT LLC, among 49 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.